SpecialtyRx Reaches Major Milestone, Now Serving 350,000 Patients Annually Across 18 States

June 18, 2026

SpecialtyRx, the nation's largest privately owned long-term care pharmacy, has announced that it now serves over 350,000 patients and 1,150 healthcare facilities annually across 18 states. This marks a significant milestone in the company's rapid national expansion.

Since operating just three pharmacy locations in 2021, SpecialtyRx has expanded to 15 full-service pharmacy locations within five years. The company now produces more than 55,000 medications daily for skilled nursing facilities, assisted living communities, rehabilitation centers, and other long-term and post-acute care providers across the country.

The milestone reflects the strength of SpecialtyRx's partnerships with care providers. Joel Zupnick, Founder of SpecialtyRx, stated, "Growth in healthcare is ultimately a reflection of trust. As long-term care providers face increasing clinical complexity and operational pressures, they need partners that can deliver consistency, reliability, and expertise at scale."

Central to SpecialtyRx's growth is its partner-first philosophy, which is designed to meet the demands of long-term care. Chesky Berkowitz, another Founder of SpecialtyRx, remarked, "The expectations placed on long-term care providers continue to evolve, and pharmacy must evolve with them."

SpecialtyRx emphasizes a robust and expanding technology platform aimed at driving better outcomes at the facility level. The company focuses on technology-enabled pharmacy solutions that help streamline workflows, reduce operational friction, and improve visibility into medication management processes.

As demand for reliable, scalable long-term care pharmacy services continues to grow, SpecialtyRx remains committed to expanding its national footprint while maintaining the personalized service model that has characterized its success.

Share
Disclaimer: This press release has been distributed on behalf of the issuing organization. PR Gun acts solely as a distribution platform and has not independently verified the accuracy, completeness, or validity of the statements contained herein.